Novo's Suit Over Compounded Weight-Loss Drug Is Tossed
By Beth JoJack · November 9, 2023, 9:09 PM EST
A Florida federal judge has issued an order dismissing Novo Nordisk Inc.'s suit against a Florida independent pharmacy for selling compounded semaglutide, a peptide also found in Ozempic, Novo's blockbuster diabetes...
To view the full article, register now.